France cuts clinical trial fees
This article was originally published in Scrip
Researchers in France no longer have to pay fees to register clinical trials withAfssaps, the national medicines regulator. A provision in the country's budget for this year took effect on January 1st, eliminating two fees that cost sponsors up to €6,000 per trial application. The change is aimed at simplifying procedures.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.